Brighton and Sussex medical school receives £1
million grant from Pfizer (UK)
19.04.2004
Brighton and Sussex Medical School (BSMS) is pleased to announce that it has received a £1 million donation from pharmaceutical company, Pfizer (UK). The innovative partnership will give BSMS, which was opened by the Secretary of State for Health in October, an important financial boost.
Professor Jon Cohen, Dean of BSMS said:
“The cash injection will make a significant difference to academic activity at the school. We are in the process of building a multi-million pound scientific research complex funded by the Science Research Investment Fund (SRIF) and this new grant will provide a welcome boost both to that development as well as underpinning the expansion of emerging research programmes, focusing on such areas as elderly care and infection”.
“The grant is particularly valuable because, as uncommitted funds, it allows us to support the research programme in both clinical and basic science.”The four key research areas for BSMS are infectious diseases, ageing and elderly care, neuro-science and cancer and genetics.
Professor Ken Miles, Professor of Imaging, said:
“Additional funding will accelerate the development of my work which includes non-invasive imaging techniques for assessing the blood supply to tumours. The more research we can do will hasten the transition of new anti-vascular cancer treatments from research to clinical practice.”
Dr Ruth Hargreaves, Medical Manager, Pfizer UK, is looking forward to working closely with the school. She said:
“This is a valuable new partnership for us where we are hoping to develop a number of joint initiatives over the years. In particular, we plan to help the students by giving them the opportunity to acquire a variety of new business skills, specifically business management, as well as working closely with them on a selection of scientific research projects. In addition, we will also be involved in the Schools’ therapeutic teaching programme and providing support to the many tutors.”
The Brighton and Sussex Medical School is an equal partnership between University
of Brighton and University of Sussex, working together with the NHS throughout
the south-east region. It is funded by the Higher Education Funding Council
for England (HEFCE) and the Department of Health.
Jon Cohen added:
“This is the start of a very exciting relationship and it is a real opportunity for us to learn from each other. As part of our wider plans we hope that other companies and organisations will consider the school as a worthwhile recipient in the future.”
- BSMS plays a key part in the Government's strategy of increasing the
number of qualified doctors from the UK working in the NHS.
- It is the first undergraduate medical school in the south-east region
outside of London.
- The first 135 students enrolled in October 2003 for the five-year programme.
- The school prides itself on providing modern practice-focused, science-based
teaching. To complement this, latest I.T. facilities make lectures interactive
and cutting edge.
- BSMS works hard to create committed and compassionate practitioners
with high quality interpersonal skills, as well as ethical standards
for professional practice, grounded in multi-professional, team-focused
work.
- Pfizer, with its UK business headquarters in Surrey and global headquarters in New York, is a research-based global pharmaceutical company. Pfizer discovers, develops, manufactures and markets leading prescription medicines for humans and animals, and many of the world's best-known consumer products. Since 1998 Pfizer has made a capital investment of more than £1billion in the UK and, following its acquisition of Pharmacia in April 2003, is the largest supplier of medicines to the NHS. It is estimated that on any given day, 40 million people around the world are treated with a Pfizer medicine.
Jon Cohen, Dean of Brighton and Sussex Medical School is available for phone interview on Monday 19th April or Tuesday 20th April. To arrange an interview please contact Emma Kearney on 020 7761 1788.
To interview Dr Ruth Hargreaves from Pfizer on Monday 19th April or Tuesday 20th April please contact Sarah Browse on 01737 332122
Contact: Marketing and Communications, University of Brighton, 01273 643022
